PacBio to Present at Upcoming Investor Conferences
09 févr. 2022 16h05 HE
|
PacBio
MENLO PARK, Calif., Feb. 09, 2022 (GLOBE NEWSWIRE) -- PacBio announced today that its executives will be speaking virtually at the following investor conferences: 11th Annual SVB Leerink Global...
PacBio to Report Fourth Quarter and Full Year 2021 Financial Results on February 15, 2022
01 févr. 2022 16h05 HE
|
PacBio
MENLO PARK, Calif., Feb. 01, 2022 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB) announced today that it will hold its quarterly conference call to discuss its fourth quarter and full year 2021 financial...
PacBio Grants Equity Incentive Award to New Employee
14 janv. 2022 16h05 HE
|
PacBio
MENLO PARK, Calif., Jan. 14, 2022 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading provider of high-quality, highly accurate sequencing platforms, today announced that the Compensation Committee...
PacBio Names Lara Toerien as Vice President and General Manager for the Americas
13 janv. 2022 07h00 HE
|
PacBio
MENLO PARK, Calif., Jan. 13, 2022 (GLOBE NEWSWIRE) -- PacBio (Nasdaq: PACB), a leading developer of high-quality, highly accurate, sequencing platforms, welcomes Lara Toerien, Ph.D., as Vice...
PacBio and Berry Genomics Announce Collaboration to Bring Long Read Desktop Sequencing Instrument to the Clinical Market in China
11 janv. 2022 07h15 HE
|
Pacific Biosciences of California, Inc.
New collaboration builds on existing relationship between the two companies to develop desktop systems for the clinical market in China Berry Genomics to purchase at least 50 instruments at product...
PacBio Announces Collaboration with Genomics England to Sequence Biobanked Rare Disease Samples Using HiFi Sequencing Technology
11 janv. 2022 07h10 HE
|
Pacific Biosciences of California, Inc.
MENLO PARK, Calif., Jan. 11, 2022 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading provider of high-quality, highly accurate sequencing platforms, today announced a collaboration with Genomics...
PacBio and Google Collaborate to Use Machine Learning to Optimize Long-Read Sequencing Data Analysis
11 janv. 2022 07h05 HE
|
Pacific Biosciences of California, Inc.
MENLO PARK, Calif., Jan. 11, 2022 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing platforms, today announced a research collaboration with...
PacBio Announces Record Preliminary Fourth Quarter 2021 Revenue, New Sequencing Kits and Workflows, and Expanded Collaborations
11 janv. 2022 07h00 HE
|
Pacific Biosciences of California, Inc.
MENLO PARK, Calif., Jan. 11, 2022 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing platforms, today announced unaudited preliminary revenue...
Radboud University Medical Center Increases HiFi Sequencing Capacity with PacBio’s Sequel IIe
07 janv. 2022 09h00 HE
|
Pacific Biosciences of California, Inc.
MENLO PARK, Calif., Jan. 07, 2022 (GLOBE NEWSWIRE) -- PacBio (Nasdaq: PACB), a leading developer of high-quality, highly accurate sequencing platforms, today announced Radboud University Medical...
Azenta Life Sciences Expands Fleet of PacBio HiFi Sequencing Systems
06 janv. 2022 09h00 HE
|
Pacific Biosciences of California, Inc.; Azenta Life Sciences
MENLO PARK, Calif., Jan. 06, 2022 (GLOBE NEWSWIRE) -- PacBio (Nasdaq: PACB) today announced an expansion of its extensive suite of HiFi applications with Azenta Life Sciences, formerly GENEWIZ. The...